Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes coronavirus
disease 2019 (COVID‐19), which may result in acute respiratory distress syndrome (ARDS) …

The airways and alveoli of the human respiratory tract are lined by two distinct types of
epithelium, which are the primary targets of respiratory viruses. We previously established …

The development of an in vitro cell model that can be used to study severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) research is expected. Here we conducted infection …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has led to the initiation of
unprecedented research efforts to understand the pathogenesis mediated by Severe Acute …

The human upper respiratory tract, specifically the nasopharyngeal epithelium, is the entry
portal and primary infection site of respiratory viruses. Productive infection of SARS-CoV-2 in …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is caused by infection with
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is spread …

Coronavirus infection causes diffuse alveolar damage leading to acute respiratory distress
syndrome. The absence of ex vivo models of human alveolar epithelium is hindering an …

Abstract Development of an anti-SARS-CoV-2 therapeutic is hindered by the lack of
physiologically relevant model systems that can recapitulate host-viral interactions in human …

The COVID-19 pandemic has emphasised the need to develop effective treatments to
combat emerging viruses. Model systems that poorly represent a virus' cellular environment …

Abstract Coronavirus disease 2019 (COVID-19) is a disease that causes fatal disorders
including severe pneumonia. To develop a therapeutic drug for COVID-19, a model that can …